TCI Wealth Advisors’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-34
Closed -$2.93K 758
2023
Q1
$2.93K Hold
34
﹤0.01% 1866
2022
Q4
$2.75K Hold
34
﹤0.01% 1894
2022
Q3
$3K Sell
34
-96
-74% -$9.45K ﹤0.01% 1752
2022
Q2
$14K Hold
130
﹤0.01% 802
2022
Q1
$12K Buy
130
+98
+306% +$9.5K ﹤0.01% 970
2021
Q4
$4K Hold
32
﹤0.01% 1794
2021
Q3
$3K Sell
32
-26
-45% -$2.56K ﹤0.01% 1921
2021
Q2
$6K Buy
58
+7
+14% +$718 ﹤0.01% 1297
2021
Q1
$5K Buy
51
+19
+59% +$1.9K ﹤0.01% 1243
2020
Q4
$3K Hold
32
﹤0.01% 1075
2020
Q3
$3K Hold
32
﹤0.01% 934
2020
Q2
$2K Buy
+32
New +$2.06K ﹤0.01% 1044
2020
Q1
Sell
-17
Closed -$1K 1536
2019
Q4
$1K Hold
17
﹤0.01% 1319
2019
Q3
$1K Buy
+17
New +$1.32K ﹤0.01% 1260

Other funds holding DORM

TCI Wealth Advisors's DORM Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Dorman Products (DORM) in Q2 2023, closing a stake of 34 shares — an estimated $2.93K sold.

TCI Wealth Advisors first reported a position in DORM in Q3 2019 and held it in 14 quarters. The position peaked at $14K in Q2 2022. 231 funds tracked by Wall St. Rank hold DORM as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Dorman Products position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 34 Dorman Products shares in Q2 2023, an estimated $2.93K.
  • TCI Wealth Advisors first reported a position in Dorman Products in Q3 2019 and held it in 14 quarters.
  • TCI Wealth Advisors's Dorman Products position peaked at $14K in Q2 2022.
  • 231 funds tracked by Wall St. Rank held Dorman Products as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.